24 Apr, 12:54 - Indian

SENSEX 79859.28 (-0.32)

Nifty 50 24264.95 (-0.26)

Nifty Bank 55332.65 (-0.07)

Nifty IT 35421.95 (0.02)

Nifty Midcap 100 55020.7 (-0.04)

Nifty Next 50 65964.95 (-0.05)

Nifty Pharma 21979.6 (1.11)

Nifty Smallcap 100 17029.75 (0.35)

24 Apr, 12:54 - Global

NIKKEI 225 35039.15 (0.49)

HANG SENG 21841.49 (-1.05)

S&P 5389 (-0.46)

LOGIN HERE
LOGIN HERE

companylogoVenus Remedies Ltd

You are Here : Home > Markets > Company Information > Profit and Loss
BSE Code : 526953 | NSE Symbol : VENUSREM | ISIN : INE411B01019 | Industry : Pharmaceuticals - Indian - Formulations |
Profit and Loss
Particulars (₹ Cr)Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue From Operations 575.21537.66576.71514.62320.23
Sale of Products564.43535.10574.52504.17314.30
Sale of Services0.000.000.000.000.00
Income from Investment and Financial Services0.000.000.000.000.00
Income from Insurance Operations0.000.000.000.000.00
Other Operating Revenue10.792.562.2010.455.93
Less: Excise Duty / GST0.000.000.000.000.00
Revenue From Operations - Net575.21537.66576.71514.62320.23
Other Income11.3210.178.4317.763.58
Total Revenue586.53547.84585.14532.39323.81
Changes in Inventories-5.0014.263.19-7.366.21
Cost of Material Consumed344.15317.28369.88344.04170.60
Internally Manufactured Intermediates Consumed0.000.000.000.000.00
Purchases of Stock-in-Trade13.075.164.430.000.00
Employee Benefits62.1351.9547.6035.8933.79
Total Other Expenses 99.9887.4882.8095.1866.57
Manufacturing / Operating Expenses14.5910.179.857.746.88
Administrative and Selling Expenses85.0777.0672.9587.4459.68
Other Expenses0.310.260.000.000.00
Finance Costs0.000.000.0012.7313.05
Depreciation and Amortization25.5531.3732.5834.2831.05
Total Expenses539.88507.51540.47514.77321.26
Profit Before Exceptional Items and Tax46.6540.3344.6717.622.55
Exceptional Items Before Tax0.000.000.0023.44-8.81
Profit Before Extraordinary Items and Tax46.6540.3344.6741.06-6.26
Extraordinary Items Before Tax0.000.000.000.000.00
Other Adjustments Before Tax0.000.000.000.000.00
Profit Before Tax46.6540.3344.6741.06-6.26
Taxation16.1511.36-4.32-13.211.96
Current Tax11.740.000.000.000.00
MAT Credit Entitlement0.000.000.000.000.00
Deferred Tax3.9311.36-4.32-13.211.96
Other Tax0.000.000.000.000.00
Adjust for Previous Year0.480.000.000.000.00
Profit After Tax30.5028.9648.9954.27-8.23
Extraordinary Items After Tax0.000.000.000.000.00
Discontinued Operations After Tax0.000.000.000.000.00
Profit / (Loss) from Discontinuing Operations0.000.000.000.000.00
Tax Expenses of Discontinuing Operations0.000.000.000.000.00
Profit Attributable to Shareholders30.5028.9648.9954.27-8.23
Adjustments to Net Income0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Profit Attributable to Equity Shareholders30.5028.9648.9954.27-8.23
Earning Per Share - Basic22.8221.6737.1243.97-6.67
Earning Per Share - Diluted22.8221.6737.1243.97-6.67

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +